Literature DB >> 2113669

Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs.

D Bordereaux1, S Fichelson, P Tambourin, S Gisselbrecht.   

Abstract

Evi-1 is a common integration site for endogenous ecotropic virus in myeloid leukemias of the AKXD mouse strain. This gene encodes a zinc finger protein with ten finger motifs. Myeloblastic leukemias obtained after infection with F-MuLV frequently exhibit proviral integration in the Fim-3 region which is genetically linked to Evi-1. This proviral integration always results in the expression of two mRNA transcripts, 5.7 kb and 4.7 kb long. We isolated two classes of cDNAs from a myeloblastic cell line with a F-MuLV provirus integrated in Fim-3. By sequence analysis, we found that one Evi-1 cDNA (E29) had an internal deletion of 972 nucleotides when compared to the full-length sequence previously published by Morishita et al. (1988). This deletion eliminated the 6th and 7th Evi-1 finger domains and was bordered by consensus donor and acceptor splice sequences. The E29 clone most likely resulted from alternative splicing of the Evi-1 gene. This was confirmed by Northern blot analysis and S1 mapping experiments. Therefore, the Evi-1 gene codes potentially for at least two proteins of 1042 and 718 amino acids differing in the numbers of their zinc-finger motifs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113669

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.

Authors:  A S Perkins; R Fishel; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 2.  Zinc finger protein genes in the mouse genome.

Authors:  A Ashworth; P Denny
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms.

Authors:  E M Klenova; R H Nicolas; H F Paterson; A F Carne; C M Heath; G H Goodwin; P E Neiman; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

4.  DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Authors:  I A Drummond; H D Rupprecht; P Rohwer-Nutter; J M Lopez-Guisa; S L Madden; F J Rauscher; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.

Authors:  C Bartholomew; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Authors:  Sonja C Bingemann; Torsten A Konrad; Rotraud Wieser
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

7.  Gene structure and alternative splicing of XFG 5-1, a X. laevis Zn finger protein with RNA homopolymer binding activity.

Authors:  M Köster; S Hille; T Pieler; W Knöchel
Journal:  Mol Biol Rep       Date:  1993-10       Impact factor: 2.316

8.  Alternative splicing and genomic structure of the Wilms tumor gene WT1.

Authors:  D A Haber; R L Sohn; A J Buckler; J Pelletier; K M Call; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.

Authors:  A Sayadi; J Jeyakani; S H Seet; C-L Wei; G Bourque; F A Bard; N A Jenkins; N G Copeland; E A Bard-Chapeau
Journal:  Oncogene       Date:  2015-08-03       Impact factor: 9.867

10.  Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Authors:  Torsten A Konrad; Anna Karger; Hubert Hackl; Ilse Schwarzinger; Irene Herbacek; Rotraud Wieser
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.